Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

3211 - 3220 of 3307 results found

Synthesis and characterization of two new mixed-ligand Cu(II) complexes of a tridentate NN'O type Schiff base ligand and N-donor heterocyclic co-ligands: In vitro anticancer assay, DNA/human leukemia/COVID-19 molecular docking studies, and pharmacophor...

Date
Wednesday, May 11, 2022 - 4:00 AM
Description
Two new mixed-ligand complexes with general formula [Cu(SB)(L')]ClO(4) (1 and 2) were synthesized and characterized by different spectroscopic and analytical techniques including Fourier transform infrared (FT-IR) and UV-Vis spectroscopy and

Synthesis and characterization of two new mixed-ligand Cu(II) complexes of a tridentate NN'O type Schiff base ligand and N-donor heterocyclic co-ligands: In vitro anticancer assay, DNA/human leukemia/COVID-19 molecular docking studies, and pharmacophor...

Date
Wednesday, May 11, 2022 - 4:00 AM
Description
Two new mixed-ligand complexes with general formula [Cu(SB)(L')]ClO(4) (1 and 2) were synthesized and characterized by different spectroscopic and analytical techniques including Fourier transform infrared (FT-IR) and UV-Vis spectroscopy and

Synthesis and characterization of two new mixed-ligand Cu(II) complexes of a tridentate NN'O type Schiff base ligand and N-donor heterocyclic co-ligands: In vitro anticancer assay, DNA/human leukemia/COVID-19 molecular docking studies, and pharmacophor...

Date
Wednesday, May 11, 2022 - 4:00 AM
Description
Two new mixed-ligand complexes with general formula [Cu(SB)(L')]ClO(4) (1 and 2) were synthesized and characterized by different spectroscopic and analytical techniques including Fourier transform infrared (FT-IR) and UV-Vis spectroscopy and

Synthesis and characterization of two new mixed-ligand Cu(II) complexes of a tridentate NN'O type Schiff base ligand and N-donor heterocyclic co-ligands: In vitro anticancer assay, DNA/human leukemia/COVID-19 molecular docking studies, and pharmacophor...

Date
Wednesday, May 11, 2022 - 4:00 AM
Description
Two new mixed-ligand complexes with general formula [Cu(SB)(L')]ClO(4) (1 and 2) were synthesized and characterized by different spectroscopic and analytical techniques including Fourier transform infrared (FT-IR) and UV-Vis spectroscopy and

Synthesis and characterization of two new mixed-ligand Cu(II) complexes of a tridentate NN'O type Schiff base ligand and N-donor heterocyclic co-ligands: In vitro anticancer assay, DNA/human leukemia/COVID-19 molecular docking studies, and pharmacophor...

Date
Wednesday, May 11, 2022 - 4:00 AM
Description
Two new mixed-ligand complexes with general formula [Cu(SB)(L')]ClO(4) (1 and 2) were synthesized and characterized by different spectroscopic and analytical techniques including Fourier transform infrared (FT-IR) and UV-Vis spectroscopy and

Safety & effectiveness of COVID-19 vaccines: A narrative review

Date
Saturday, April 30, 2022 - 4:00 AM
Description
There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world's population during the COVID-19 pandemic. Though research is being published all over the

Social Determinants related to COVID-19 Infection

Date
Saturday, April 30, 2022 - 4:00 AM
Description
This study was aimed to identify the social determinants related to COVID-19 infection. This secondary data analysis study used data from 2020 Community Health Survey, a nationwide sample survey to understand the health status of Korean residents